$TRYP – Tidal ETF Trust, promotional campaign starting Oct 24, 2021 @ 3:01 PM CST

on October 24, 2021 Stock Promotion Tracking and Tags: , , , , , , , , , with 0 comments

Summary

Start time:
3:01 PM
Start date:
October 24, 2021
Symbol:
TRYP
Company:
Tidal ETF Trust
Stock promoter:
"Tip"
Stock promoter rank:
12 out of 25
Promoter score:
14.0
Campaign ID:
36760

Tidal ETF Trust

Stock Promoter Performance

The following charts displays the first day results for campaigns by "Tip". Results are taken from a total of 26 stock promotions by this stock promoter that have been tracked by OTC Dynamics.
36% closed down

42% closed up

21% had no net effect

Last 4 Stock Promotions By "Tip"

Symbol Company Start Date Close Change
INND Innerscope Hearing Technologies, Inc. October 17, 2021 0.0089 -2%
IWBB Iweb Inc. October 10, 2021 2.45 -2%
LQWDF LQwD FinTech Corp. October 3, 2021 0.287 -5%
AVCRF Avricore Health Inc. September 26, 2021 0.128 2%

TRYP Promotional Newsletter

The following is a newsletter released by "Tip" promoting Tidal ETF Trust

Caution

The following newsletter has not been verified for accuracy or completeness.

Tryp Therapeutics Inc.CSE TRYP OTCQB TRYPF

Tryp Therapeutics Inc. CSE OTCQB is leading the next wave of psychedelic drug development beyond mental health with its focus on psilocybin-based treatments for chronic pain and other indications. The company was founded in 2019 and is headquartered in San Diego, California.

Innovative Drug Pipeline

Tryps Psilocybin-for-Neuropsychiatric Disorders PFN program is focused on the development of synthetic psilocybin for chronic pain and other indications.

The company has announced plans to initiate four upcoming Phase 2a clinical trials in fibromyalgia, phantom limb pain, complex regional pain syndrome CRPS, and certain overeating disorders binge eating disorder and hypothalamic obesity. At least two of the Phase 2a studies are expected to begin enrolling patients in 2021.

The companys development plans cover three strategic initiatives

Innovate Tryp is using its unique drug products to pursue chronic pain and other indications that most other psychedelic companies are not through collaborations with leading academic institutions such as the University of Michigan, the University of Florida, and others.
Develop Tryp intends to utilize the FDAs 505b2 regulatory pathway with available third-party preclinical data to shorten the timelines and lower the cost of its development programs.
Protect Tryp plans to utilize regulatory exclusivity, patents, trade secrets and proprietary know-how to protect the commercial lifespan of its drug candidates.

Recent Coverage

Tryp Therapeutics Inc. CSE TRYP OTCQB TRYPF Announced Inclusion in AdvisorShares Psychedelics ETF KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

October 21, 2021 1230 PM

Tryp announced its inclusion in the AdvisorShares Psychedelics ETF
The company hopes that its participation will open it up to a more diverse shareholder base and broaden its life science exposure
Tryps presentation at the KCSA Virtual Investor Conference will also be available for on-demand viewing over the next 90 days

Launched back in September 2021, the AdvisorShares Psychedelics Exchange-Traded Fund ETF has been actively trading, focusing on enterprises that have devoted a significant proportion of their assets to psychedelic drug development. Operating under the ticker symbol PSIL on the New York Stock Exchange NYSE Arca exchange, this fund has built a portfolio that includes over 25 different psychedelic companies. is the latest addition to that group.

Other companies we are watching

Tip Us Off

Know of a stock poised to make a big move Tell us which one and why We're constantly scanning the headlines and keeping tabs on what's hot, but can always use an extra hand. Whether amateur or pro, you're more than welcome to join in on the fun

Sign Up For Instant Alerts

Micro-cap stocks can make rapid moves of 50% or more, making the latest information extremely critical to maximizing profits.

Please read for FULL Compensation Disclosures and other disclaimers.
Copyright 2012-2018.

Get Every Penny Stock Alert!

OTC Dynamics tracks all penny stock promotions. Become a member today and never miss another penny stock promotion!

Sign up today!

Note

OTC Dynamics is not affiliated with the company being promoted or the associated stock promoter.

The information on this page is not a recommendation to buy or sell securities.